Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pegylated IFN-alpha 2b added to ongoing lamivudine therapy in patients with lamivudine-resistant chronic hepatitis B.
Vassiliadis T, Patsiaoura K, Tziomalos K, Gkiourtzis T, Giouleme O, Grammatikos N, Rizopoulou D, Nikolaidis N, Katsinelos P, Orfanou-Koumerkeridou E, Eugenidis N. Vassiliadis T, et al. Among authors: grammatikos n. World J Gastroenterol. 2006 Apr 21;12(15):2417-22. doi: 10.3748/wjg.v12.i15.2417. World J Gastroenterol. 2006. PMID: 16688836 Free PMC article.
Adefovir dipivoxil added to ongoing lamivudine therapy in patients with lamivudine-resistant hepatitis B e antigen-negative chronic hepatitis B.
Vassiliadis T, Nikolaidis N, Giouleme O, Tziomalos K, Grammatikos N, Patsiaoura K, Zezos P, Gkisakis D, Theodoropoulos K, Katsinelos P, Orfanou-Koumerkeridou E, Eugenidis N. Vassiliadis T, et al. Among authors: grammatikos n. Aliment Pharmacol Ther. 2005 Mar 1;21(5):531-7. doi: 10.1111/j.1365-2036.2005.02388.x. Aliment Pharmacol Ther. 2005. PMID: 15740536
Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients.
Nikolaidis NL, Giouleme OI, Tziomalos KA, Saveriadis AS, Grammatikos N, Doukelis P, Voutsas AD, Vassiliadis T, Patsiaoura K, Orfanou-Koumerkeridou E, Balaska A, Eugenidis NP. Nikolaidis NL, et al. Among authors: grammatikos n. J Gastroenterol Hepatol. 2005 Nov;20(11):1721-5. doi: 10.1111/j.1440-1746.2005.04029.x. J Gastroenterol Hepatol. 2005. PMID: 16246192 Clinical Trial.
Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B.
Vassiliadis T, Tziomalos K, Patsiaoura K, Zagris T, Giouleme O, Soufleris K, Grammatikos N, Theodoropoulos K, Mpoumponaris A, Dona K, Zezos P, Nikolaidis N, Orfanou-Koumerkeridou E, Balaska A, Eugenidis N. Vassiliadis T, et al. Among authors: grammatikos n. J Gastroenterol Hepatol. 2007 Oct;22(10):1582-8. doi: 10.1111/j.1440-1746.2007.05103.x. Epub 2007 Aug 7. J Gastroenterol Hepatol. 2007. PMID: 17683500
Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: a 4-year study.
Vassiliadis TG, Giouleme O, Koumerkeridis G, Koumaras H, Tziomalos K, Patsiaoura K, Grammatikos N, Mpoumponaris A, Gkisakis D, Theodoropoulos K, Panderi A, Katsinelos P, Eugenidis N. Vassiliadis TG, et al. Among authors: grammatikos n. J Gastroenterol Hepatol. 2010 Jan;25(1):54-60. doi: 10.1111/j.1440-1746.2009.05952.x. Epub 2009 Sep 22. J Gastroenterol Hepatol. 2010. PMID: 19780875 Clinical Trial.
16 results